Clinical Trials Browser

Paraganglioma, Pheochromocytoma

Lung Neoplasms, Small Cell Lung Carcinoma

Neoplasm Metastasis, Sarcoma, Ewing

Brain Neoplasms, Glioblastoma

Glioblastoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Colorectal Neoplasms, Microsatellite Instability

Advanced Melanoma

Glioblastoma, Gliosarcoma

Ependymoma, Medulloblastoma, Recurrence

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Glioblastoma

Neuroblastoma

Neuroblastoma

Glioblastoma

Ependymoma, Medulloblastoma

Glioblastoma

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Glioblastoma

Glioblastoma

Primary Glioblastoma

Glioblastoma

Astrocytoma, Glioblastoma, Oligodendroglioma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

Leiomyosarcoma, Sarcoma

Glioblastoma

Somatostatinoma, Carcinoma, Neuroendocrine

Glioblastoma

Lung Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Adenoma, Islet Cell

Triple Negative Breast Neoplasms

Glioblastoma

Neuroendocrine Tumors

Glioblastoma

Paraganglioma, Pheochromocytoma

Glioblastoma, Glioma, Gliosarcoma

Glioblastoma

Small Cell Lung Carcinoma

Neuroblastoma

Small Cell Lung Carcinoma

Fallopian Tube Neoplasms, Ovarian Neoplasms

Glioblastoma, Meningeal Carcinomatosis

Glioblastoma

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Clinical Trials

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Surgical Pembro +/- Olaparib w TMZ for rGBM

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

ARETHUSA

A Phase II Trial of LM103 in Advanced Melanoma

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

MEMMAT

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

2-THE-TOP

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

ARISTOCRAT

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

MATVAC-1

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

PNOC031

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Newly Diagnosed Glioblastoma

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma

Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme

Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

CapTemY90

hSTAR GBM

Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

TRIO-US L-07

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread

G-CSF After Chemo-radiation in Patients With Glioblastoma

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma